Pretreatment Tumor NECTIN4 RNA Expression Is Associated with First-line Enfortumab Vedotin Plus Pembrolizumab Efficacy in Metastatic Urothelial Cancer

Study limitation reported by the research below: “The pembrolizumab monotherapy comparator cohort (N=232) likely represents a historically treated population and may not be directly comparable to the EV+P cohort.”